About Us

   Suck W. Kim's
   Publications

   Jon E. Grant's
   Publications

   Brian L. Odlaug's
   Publications

Principles of Treatment

News

Media Coverage

Publications

What is craving?

Brain Imaging Studies

Reinforcement Learning

Recommended Reading

Useful Links

Contributions

Disclaimer and Privacy

Impulse Control Disorders Clinic Home

Suck Won Kim's Scientific Publications

Selected Publications

1) Kim SW, Dysken MW, Kline MD: Monozygotic twins with Obsessive Compulsive Disorder. British Journal of Psychiatry 156:435-438, 1990.

2) Kim SW, Dysken MW, Kuskowski M: The Yale-Brown Obsessive Compulsive Scale (Y-BOCS): A reliability and validity study, Psychiatry Research 34:99-106, 1990.

3) The Clomipramine Collaboration Group: Clomipramine hydrochloride in the treatment of patients with Obsessive Compulsive Disorder. Archives of General Psychiatry 48:730-738, 1991 (DeVeaugh-Geiss J, Katz R, Landau P, Akiskal H, Ananth J, Ballenger J, Betts W, Diamond B, Feiger A, Foa E, Fogelson D, Goodman W, Greist J, Himmelhoch J, Hoen-Saric R, Jenike M, Kim S, Liebowitz M, Mavissakalian N, Ninan P, Noyes R, Rasmussen S, Ringold A, Shear K).

4) Kim SW, Dysken MW, Pandey SN, Davis JM: Platelet tritiated imipramine binding sites in Obsessive-Compulsive behavior. Biological Psychiatry 30:467-474, 1991.

5) Christensen KJ, Kim SW, Dysken MW, Maxwell KT: Neuropsychological performance in Obsessive Compulsive Disorder. Biological Psychiatry 31:4-18, 1992.

6) Kim SW, Dysken MW, Kuskowski M: The Symptom Checklist-90: Obsessive Compulsive Subscale (SCL-90-OCS); A reliability and validity study. Psychiatry Research 41:37-44, 1992.

7) Dysken MW, Kim SW, Vatassery G, Johnson SB, Skare S, Holden L, Thomsyck L: Haloperidol decanoate pharmacokinetics in RBC and plasma. Journal of Clinical Psychopharmacology 12:128-132, 1992.

8) Schenck CH, Mahowald MW, Kim SW, O'Connor KA, Hurwitz TD: Prominent eye movements during NREM sleep and REM sleep behavior disorder associated with fluoxetine treatment of depression and Obsessive Compulsive Disorder. Sleep 15:226-235, 1992.

9) Kim SW, Dysken MW, Goldsmith SR: Target symptom oriented treatment of panic attacks with sublingual alprazolam Annals of Clinical Psychiatry 4:147-149:1992.

10) Pandey GN, Kim SW, Pandey SC, Davis JM: Platelet serotonin-2 (5-HT2) receptor binding sites in Obsessive Compulsive Disorder. Biological Psychiatry 33:367-372, 1993.

11) Kim SW, Dysken M, Kuskowski M, Hoover KM: The Yale-Brown Obsessive Compulsive Scale (Y-BOCS) and the NIMH Global Obsessive Compulsive Scale (NIMH-GOCS): A reliability and validity study. International Journal of Methods in Psychiatric Research 3:37-44, 1993.

12) Kim SW: Japan's SAT? Science (letter) 260:278, 1993.

13) Kuskowski M, Malone SM, Kim SW, Dysken MW, Okaya AJ, Christensen KJ: Quantitative EEG in Obsessive Compulsive Disorder. Biological Psychiatry 33:423-430, 1993.

14) Kim SW, Dysken MW, Pheley AM, Hoover KM: The Yale-Brown Obsessive Compulsive Scale (Y-BOCS): Measures of internal consistency. Psychiatry Research 51:203-211, 1994.

15) Greist JH, Chouninard G, DuBoff E, Halaris A, Kim SW, Korran L, Liebowitz M, Lydiard RB, Mendels J, Rasmussen S, White K, Sikes C: Double-blind parallel comparison of three doses of sertraline and placebo in outpatients with Obsessive Compulsive Disorder. Archives of General Psychiatry 52:289-295, 1995.

16) Greist JH, Jefferson JW, Kovak KA, Chouinard G, DuBoff E, Halaris A, Kim SW, Koran L, Liebowitz M, Lydiard RB, McElroy S, Mendels J, Rasmussen S, White K, Flicker C: A one-year double-bline placebo-controlled fixed dose study of sertraline in the treatment of Obsessive Compulsive Disorder. Inernational Clinical Psychopharmacology 10:57-65, 1995.

17) Kim SW, Hoover KM: Tridimensional Personality Questionnaire (TPQ): Assessment in Social Phobia and Controls. Psychological Reports 78:43-49, 1996.

18) Zald DH, Kim SW: The Anatomy and function of the Orbital Frontal Cortex: Part I: Anatomy, neurocircutry, and their relevance to Obsessive-Compulsive Disorder. Journal of Neuropsychiatry and Clincial Neurosciences 8:125-138, 1996.

19) Zald DH, Kim SW: The Anatomy and function of the Orbital Frontal Cortex: Part II: Function and relevance to Obsessive-Compulsive Disorder. Journal of Neuropsychiatry and Clincial Neurosciences 8:249-261, 1996.

20) Hartman BK, Faris PL, Kim SW, Raymond NC, Goodale RL, Meller WH, Eckert ED: Treatment of bulimia nervosa with ondansetron. Archives of General Psychiatry (letter) 54:969-970, 1997.

21) Kim SW, Dysken MW, Kushner MG, Hoover KM, Klein KW, Faris PL, Hartman BK: Phenomenological and pharmacological study of provoked obsessive/anxiety symptoms in OCD: A preliminary study. Biological Psychiatry 42:969-975, 1997.

22) Kim SW: Opioid antagonists in the treatment of impulse-control disorders. Journal of Clinical Psychiatry 58:159-164, 1998.

23) Gruetter R, Seaquist ER, Kim SW, Ugurbil K: Localized in vivo 13C NMR of glutamate metabolism in the human brain: Initial Resutls at 4 tesla. Developmental Neuroscience 20:380-388, 1998.

24) Faris PL, Kim SW, Meller WH, Goodale RL, Hofbauer RD, Oakman SA, Howard LA, Stevens ER, Eckert ED, Hartman BK: Effect of ondansetron, a 5-HT3 receptor antagonist, on the dynamic association between bulimic behaviors and pain thresholds. Pain 77:297-303, 1998.

25) Faris, PL, Kim SW, Meller WH, Goodale RL, Oakman SA, Hofbauer RD, Marshall AM, Daughters RS, Banerjee-Stevens DJ, Eckert ED, and Hartman BK. Effect of decreasing afferent vagal activity with ondansetron on symptoms of bulimia nervosa: a randomised, double-blind trial. The Lancet 355: 792-797, 2000.

26) Kim SW, Grant JE. Psychopharmacology of pathological gambling. Seminars in Clinical Neuropsychiatry 6:184-194,2001.

27) Kim SW, Grant JE. An open naltrexone treatment study in pathological gambling disorder. International Clinical Psychopharmacology 16:285-289, 2001.

28) Kim SW, Grant JE, Adson D, Shin YC: Double-blind naltrexone and placebo comparison study in the treatment of pathological gambling. Biological Psychiatry 49:914-921, 2001.

29) Grant JE, Kim SW, Brown EM. Characteristics of geriatric patients seeking medical treatment for pathological gambling disorder. Journal of Geriatric Psychiatry and Neurology 14:125-129, 2001.

30) Grant JE, Kim SW, Crow SJ. Prevalence and clinical features of body dysmorphic disorder in adolescent and adult psychiatric inpatients. Journal of Clinical Psychiatry 62:517-522, 2001.

31) Holden C: 'Behavioral' Addictions: do they exist? (a summary of interview with Kim SW on the opioid antagonist in the treatment of Impulse-Control Disorders and others on the subject of behavioral addictions) Science 294:980-982, 2001.

32) Kim SW, Grant JE, Adson DE, Remmel RP. A Preliminary report on possible naltrexone and nonsteroidal analgesics interaction. Journal of Clinical Psychopharmacology 21:632-633, 2001.

33) Grant JE, Kim SW: Demographics and clinical features of 131 adult pathological gamblers. Journal of Clinical Psychiatry 62:957-962, 2001.

34) Grant JE, Kim SW: A case of kleptomania and compulsive sexual behavior treated with naltrexone. Annals of Clinical Psychiatry 13:205-207, 2001.

35) Kim SW, Grant JE. Personality dimensions in pathological gambling disorder and obsessive-compulsive disorder. Psychiatry Research 104:205-212, 2001.

36) Grant JE, Kim SW: Gender differences in pathological gamblers seeking medication treatment. Comprehensive Psychiatry 43:56-62, 2002.

37) Grant JE, Kim SW. Pharmacotherapy of pathological gambling. Psychiatric Annals 32:186-191, 2002.

38) Grant JE, Kim SW: Temperament and early environment influences in kleptomania. Comprehensive Psychiatry 43:223-229, 2002.

39) Grant JE, Kim SW: An open label study of naltrexone in the treatment of kleptomania. Journal of Clinical Psychiatry 63:349-356, 2002.

40) Grant JE, Kim SW: Clinical characteristics and associated psychopathology in 22 patients with kleptomania. Comprehensive Psychiatry 43:378-384, 2002.

41) Kim SW, Grant JE, Adson DE, Shin YC, Zaninelli R: A double-blind, placebo-controlled study of the efficacy and safety of paroxetine in the treatment of Pathological Gambling Disorder. Journal of Clinical Psychiatry 63:501-507, 2002.

42) Grant JE, Kim SW, Eckert ED: Body Dysmorphic Disorder in patients with Anorexia Nervosa: prevalence, clinical features, and delusionality of body image. International Journal of Eating Disorders 32:291-300, 2002.

43) Raymond NC, Grant JE, Kim SW, E Coleman: Treatment of compulsive sexual behavior with naltrexone: two case studies. International Clinical Psychopharmacology 17:201-205, 2002.

44) Grant JE, Kushner MG, Kim SW: Pathological gambling and alcohol use disorder. Alcohol Research & Health 26:143-150, 2002.

45) Grant JE, Kim SW: Adolescent kleptomania treated with naltrexone: A case report. European Child & Adolescent Psychiatry 11:92-95, 2002.

46) Kim SW, Grant JE, Grosz RL: Pathological gambling: current status and new treatments. Minnesota Medicine 85:48-52, 2002.

47) Grant JE, Kim SW: Effectiveness of pharmacotherapy for pathological gambling. Annals of Clinical Psychiatry 14:155-161, 2002.

48) Grant JE, Kim SW, Potenza MN, Blanco C, Ibanez A, Stevens L, Hektner JM, Zaninelli R: Paroxetine treatment of pathological gambling: A multi-center randomized controlled trial. International Clinical Psychopharmacology 18:243-249, 2003.

49) Grant JE, Kim SW. Comorbidity of impulse control disorders in pathological gamblers. Acta Psychiatrica Scandinavica 108:203-207, 2003.

50) Grant JE, Kim SW, Potenza MN: Advances in the pharmacological treatment of pathological gambling. Journal of Gambling Studies 19:85-109, 2003.

51) Grant JE, Kim SW: Dissociative Symptoms in Pathological Gambling. Psychopathology 36:200-203, 2003.

52) Stephan E, Pardo JV, Faris PL, Hartman BK, Kim SW, Ivanov EH, Saughters RS, Costello PA, Goodale RL: Functional neuroimaging of gastric distention. Journal of Gastrointestinal Surgery 7:740-749, 2003.

53) Kim SW, Grant JE, Kim SI, Swanson TA, Bernstein GA, Jaszcz WA, Williams KA, Schlievert PM: A Possible association of recurrent Streptococcal infections and acute onset of obsessive-compulsive disorder. Journal of Neurospychiatry and Clinical Neurosciences 16:252-260, 2004.

54) al'Absi M, Wittmers LE, Ellestad D, Nordehn G, Kim SW, Kirschbaum C, Grant JE: Sex differences in pain and hypothalamic-pituitary-adrenocortical responses to opioid blockade. Psychosomatic Medicine 66:198-206, 2004.

55) Grant JE, Steinberg M, Kim SW, Rounsaville B, Potenza MN: Preliminary validity and reliability testing of a Structured Clinical Interview for Pathological Gambling (SCI-PG). Psychiatry Research 128:79-88, 2004.

56) Grant JE, Kim SW: Quality of life in kleptomania and pathological gambling. Comprehensive Psychiatry 46:34-37, 2005.

57) Grant JE, Kim SW, McCabe J: A Structured Clinical Interview for Kleptomania (SCI-K): preliminary validity and reliability testing. International Journal of Methods in Psychiatric Research (in press).

58) Kim SW, Grant JE, Eckert ED, Paris PL, Hartman BK: Pathological gambling and mood disorders: clinical associations and treatment implications. Journal of Affective Disorder 92:109-116, 2006.

59) Faris PL, Eckert ED, Kim SW, Meller WH, Pardo JV, Goodale RL, Hartman BK: Evidence for a vagal pathophysiology for bulimia nervosa and the accompanying depressive symptoms. Journal of Affective Disorder 92:79-90, 2006.

60) Kim SW, Grant JE, Yoon GH, Kyle WA, Remmel RP: Safety of high dose naltrexone treatment: hepatic transaminase profiles among outpatients. Clinical Neuropharmacology 29:77-79, 2006.

61) Yoon GH, Kim SW, Thuras P, Grant JE, Westermeyer J: Alcohol craving in outpatients with Alcohol Dependence: Rate and clinical correlates. Journal of Studies on Alcohol (in press).

62) Grant JE, Williams KA, Kim SW: Update on pathological gambling. Current Psychiatry Report 8:53-58, 2006.

63) Eckert ED, Kim SW: Guest editorial for special festschrift edition honoring Paula Clayton for the Journal of Affective Disorders. Journal of Affective Disorder 92:3-5, 2006.

(back to top)

Books and Book Chapters

1) Kim SW: Panic Disorders, in Tintinalli JE, Krome RL, Ruiz E (eds); Emergency Medicine - A comprehensive study guide (3rd ed)(American College of Emergency Physicians). New York, McGraw-Hill Companies, 1992 (revised 1995).

2) Kim SW: Measuring outcome in drug trials of obsessive compulsive disorder. In Goodman WK, Rudorfer MV, Maser JD (eds); Obsessive Compulsive Disorder. Lawrence Erlbaum Associate Inc, Mahwah, NJ, 2000.

3) Zald DH, Kim SW: The orbitofrontal cortex. In Salloway SP, Malloy PF, Duffy JD (eds); The frontal lobes and neuropsychiatric illness. American Psychiatric Publishing, Inc. Washington, DC, 2001.

4) Grant JE, Kim SW: Stop me because I can't stop myself: Taking control of impulsive behavior. McGraw-Hill Companies, 2002.

5) Williams KA, Grant JE, Schlievert PM, Kim SW: Exploring the pathophysiology of PANDAS: Streptococcus, Sydenham's, and superantigens in Neuropsychiatric Disorders and Infection S. Hossein Fatemi (ed), Taylor & Francis, London, UK, 2005.

6) Grant JE, Kim SW: Gender related differences in Pathological Gambling Disorder. In Pathological Gambling Disorder (Eds. Grant JE, Potenza MN), American Psychiatric Press (In press).

7) Williams KA, Murphy ML, Grant JE, Kim SW: The PANDAS subgroup: from hypothesis to treatment (in press).

8) Kim SW, Grant JE, Yoon GH, Potenza MN: Psychopharmacological management of pathological gambling (in press).

(back to top)